However, EPCAM is specific for well-differentiated epithelial cells and is one of the first epithelial markers lost on CTCs during the epithelial-to-mesenchymal transition (EMT) process before other epithelial markers which is associated with increased invasiveness and metastasis of cancer cells [28]. This evidence concerns the gene EPCAM and cancer.